Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens

Luis Paz-Ares, Vera Hirsh, Li Zhang, Filippo De Marinis, James Chih Hsin Yang, Heather A. Wakelee, Takashi Seto, Yi Long Wu, Silvia Novello, Erszébet Juhász, Osvaldo Arén, Yan Sun, Thomas Schmelter, Teng Jin Ong, Carol Penã, Egbert F. Smit, Tony S. Mok

Research output: Contribution to journal › Article › peer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science